Skip to content

Understanding Treatment Affordability: How Much Does Verkazia Cost?

3 min read

In the United States, the prevalence of vernal keratoconjunctivitis (VKC) among individuals under 18 is estimated to be 1.24 per 10,000 people [1.9.5]. For those diagnosed, a key question is: How much does Verkazia cost?

Quick Summary

Verkazia's retail price can exceed $1,800 for a typical supply. Costs vary based on pharmacy, insurance coverage, and patient savings programs, which can significantly lower out-of-pocket expenses.

Key Points

  • High Retail Price: Verkazia's retail cost without insurance can be over $2,100, with coupon prices around $1,800 [1.2.1].

  • Specific Indication: It is specifically FDA-approved for vernal keratoconjunctivitis (VKC), not general dry eye [1.5.1].

  • Insurance is Key: Insurance coverage is the primary determinant of out-of-pocket cost, with some insured patients paying around $90 [1.2.4].

  • Manufacturer Savings: Eligible, commercially insured patients may pay as little as $0 with the Harrow Savings Program [1.4.2].

  • Cash-Payer Savings: Uninsured or cash-paying patients may be able to reduce the cost to as little as $79 through manufacturer programs [1.4.5].

  • No Generic Available: Verkazia is a brand-name-only drug, contributing to its high cost [1.8.1].

  • Dosing Differences: Verkazia is dosed four times daily, unlike other cyclosporine drops like Restasis and Cequa which are dosed twice daily [1.5.5, 1.8.1].

In This Article

What is Verkazia and Why Is It Prescribed?

Verkazia (cyclosporine ophthalmic emulsion) 0.1% is a prescription eye drop approved by the FDA for the treatment of a severe and chronic allergic eye condition called vernal keratoconjunctivitis (VKC) [1.5.3, 1.5.1]. This condition primarily affects children and young adults, causing significant eye inflammation, itching, light sensitivity, and discharge [1.5.2, 1.9.2]. Unlike other cyclosporine eye drops like Restasis or Cequa, which are approved for dry eye disease, Verkazia is specifically indicated for VKC [1.5.1, 1.8.1]. It is not a steroid; it belongs to a class of drugs called calcineurin inhibitors, which work by suppressing the immune response and reducing the inflammation that causes VKC symptoms [1.5.1, 1.6.2]. Treatment typically involves instilling one drop into the affected eye(s) four times daily [1.5.5].

The Retail Cost of Verkazia Without Insurance

For patients paying without insurance, the cash price of Verkazia can be substantial. The average retail price for the most common version of Verkazia is approximately $2,173, though prices can fluctuate [1.2.1]. With coupons from services like GoodRx, the price can be lowered to around $1,802 for a supply of 120 single-dose vials [1.2.1, 1.2.5]. Prices also vary between pharmacies. For example, a 120-vial supply might cost around $1,827 at CVS, $1,897 at Walmart, and $2,026 at Costco [1.2.1]. Some sources report prices as high as $1,995 for a one-month supply [1.3.5]. This high cost is because Verkazia is a brand-name medication with no generic equivalent currently available [1.6.2, 1.8.1].

Factors Influencing Verkazia's Price

The price a patient pays for Verkazia is influenced by several key factors:

  • Pharmacy: As shown, different pharmacies have different retail prices for the same medication [1.2.1, 1.3.4].
  • Insurance Coverage: A patient's final cost heavily depends on their prescription drug plan. Each insurance company has its own formulary, which determines how much of the drug's cost is covered [1.3.5]. With good insurance, some patients pay as little as $90 [1.2.4].
  • Deductibles and Copayments: Even with insurance, patients may need to meet a deductible before coverage kicks in, after which they will pay a copayment or coinsurance amount.
  • Savings Programs: Manufacturer coupons and patient assistance programs can dramatically reduce the out-of-pocket expense for eligible patients [1.4.1, 1.4.2].

How to Reduce the Cost of Verkazia

Given the high retail price, finding ways to reduce the cost is crucial for many patients. Fortunately, several options are available.

Manufacturer Savings Programs

The manufacturer, Harrow, offers savings programs to help make Verkazia more affordable. The Harrow Savings Program allows commercially insured patients to pay as little as $0 for their prescription [1.4.2, 1.4.1]. For patients without insurance coverage or those paying with cash, this program can reduce the cost to as little as $79 per prescription [1.4.1, 1.4.5]. It's important to note that these programs are not valid for patients covered by government-funded programs like Medicare or Medicaid [1.4.2].

Prescription Discount Cards

Services like GoodRx and SingleCare offer free coupons that can provide significant savings off the retail price of Verkazia [1.2.1, 1.3.5]. For instance, a coupon could reduce the cost from over $2,100 to around $1,808 [1.3.1]. These cards are widely accepted at major chain pharmacies and are a viable option for those without insurance or with high-deductible plans [1.4.6].

Comparison of Cyclosporine Eye Drops

Verkazia is one of several cyclosporine-based eye drops on the market. While they share the same active ingredient, they have different formulations, approved uses, and costs.

Feature Verkazia Restasis Cequa
Active Ingredient Cyclosporine 0.1% [1.5.3] Cyclosporine 0.05% Cyclosporine 0.09% [1.8.5]
Approved Use Vernal Keratoconjunctivitis (VKC) [1.5.1] Chronic Dry Eye [1.8.1] Chronic Dry Eye [1.8.1]
Dosage 4 times daily [1.5.5] 2 times daily [1.8.1] 2 times daily [1.8.1]
Formulation Cationic oil-in-water emulsion Emulsion Nanomicellar aqueous solution [1.8.5]
Generic Available? No [1.6.2] Yes [1.8.1] No
Approx. Retail Cost ~$1,800 - $2,200 [1.2.1, 1.3.5] ~$400 (Brand) [1.3.5] ~$784 [1.3.5]

Conclusion

The answer to "How much does Verkazia cost?" is complex, with a high retail price that can be significantly reduced through various means. The list price often exceeds $1,800, but insurance coverage is the single most important factor in determining a patient's out-of-pocket expense. For those with commercial insurance, manufacturer savings programs can lower the cost to as little as $0 [1.4.2]. For the uninsured, prescription discount cards offer a way to get a lower price than retail. Patients should discuss their options with their doctor and pharmacist to find the most affordable way to access this necessary treatment for VKC. For more details, you can visit the official Verkazia website.

Frequently Asked Questions

The retail cost for a one-month supply (typically 120 vials) can range from $1,800 to over $2,100 without insurance [1.2.1, 1.2.5]. With manufacturer coupons, this can be reduced to as little as $79 for cash payers or $0 for eligible commercially insured patients [1.4.1, 1.4.2].

No, there is currently no generic version of Verkazia available [1.8.1]. It is only available as a brand-name medication.

Many insurance plans cover Verkazia, but coverage varies. Your final copay will depend on your specific plan's formulary and deductible [1.3.5]. Some insured patients report paying around $90 [1.2.4].

Both contain cyclosporine, but Verkazia (0.1%) is approved for vernal keratoconjunctivitis (VKC) and is dosed four times a day. Restasis (0.05%) is approved for chronic dry eye, is dosed twice a day, and has a generic equivalent available [1.8.1].

The manufacturer offers a savings program where commercially insured patients may pay as little as $0 [1.4.2]. Patients without insurance can also use this program to potentially pay as little as $79 [1.4.5]. Prescription discount cards like GoodRx are another option to lower the retail price [1.2.1].

Verkazia is an FDA-approved prescription eye drop used to treat vernal keratoconjunctivitis (VKC), a severe, chronic allergic eye condition that causes inflammation on the surface of the eye [1.5.3, 1.5.1].

The most common side effects are temporary eye pain (reported in 12% of patients) and eye itching (8%), which typically occur during instillation of the drops [1.7.1, 1.7.3].

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.